Mesa Laboratories, Inc.
MLAB
$71.62
-$2.32-3.14%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.02% | 2.36% | 5.49% | 17.52% | 8.78% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.02% | 2.36% | 5.49% | 17.52% | 8.78% |
| Cost of Revenue | 6.76% | 12.22% | 12.33% | 15.02% | 4.12% |
| Gross Profit | 3.96% | -2.86% | 1.66% | 19.02% | 11.83% |
| SG&A Expenses | 0.90% | 7.27% | 13.31% | -0.87% | 0.50% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.98% | 9.01% | 11.47% | 6.58% | 1.21% |
| Operating Income | 19.23% | -51.81% | -67.20% | 8,725.37% | 6,703.33% |
| Income Before Tax | -47.56% | 79.56% | 100.17% | -213.93% | 387.70% |
| Income Tax Expenses | -224.22% | 339.07% | 136.51% | -218.24% | 504.21% |
| Earnings from Continuing Operations | -27.77% | 39.96% | 97.21% | -179.21% | 378.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.77% | 39.96% | 97.21% | -179.21% | 378.70% |
| EBIT | 19.23% | -51.81% | -67.20% | 8,725.37% | 6,703.33% |
| EBITDA | 5.41% | -23.70% | -16.77% | 25.54% | 24.81% |
| EPS Basic | -29.07% | 38.21% | 97.23% | -178.67% | 377.40% |
| Normalized Basic EPS | -53.98% | 285.53% | 6.43% | -213.17% | 420.49% |
| EPS Diluted | -28.70% | 37.10% | 97.23% | -179.49% | 373.91% |
| Normalized Diluted EPS | -53.68% | 281.26% | 6.43% | -213.22% | 417.05% |
| Average Basic Shares Outstanding | 1.83% | 1.26% | 0.83% | 0.67% | 0.48% |
| Average Diluted Shares Outstanding | 1.17% | 2.38% | 0.83% | 0.61% | 1.56% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 0.41% | -0.28% | -35.04% | -2.27% | 1.36% |